Kemonac 600 EF Tablet Orange contains Acetylcysteine 600 mg, a mucolytic agent widely used to manage respiratory conditions characterized by excessive or thick mucus production. Acetylcysteine acts by breaking disulfide bonds in mucoproteins, thereby reducing the viscosity and elasticity of mucus, facilitating its clearance from the respiratory tract. This improves airway patency and enhances expectoration in patients suffering from chronic bronchitis, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other pulmonary disorders associated with impaired mucus clearance. Additionally, Acetylcysteine serves as an effective antidote in acetaminophen (paracetamol) overdose by replenishing intracellular glutathione stores, thus preventing hepatic injury. Kemonac 600 EF Tablet Orange is administered orally, with the orange flavor improving patient compliance. It is generally well tolerated, though adverse effects may include gastrointestinal discomfort, nausea, and rarely, hypersensitivity reactions. Caution is advised in patients with asthma or a history of bronchospasm. Dosage should be individualized based on clinical condition and physician guidance. This medication should be used under medical supervision, especially in patients with underlying hepatic or renal impairment. Kemonac 600 EF Tablet Orange offers a reliable therapeutic option for managing mucus-related respiratory conditions and acetaminophen toxicity.